| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2020 - PRIN bando 2020 |
RE-Plast: targeting functional and structural plasticity in Alzheimer disease. From diagnosis to treatment
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Dissecting the role of anti-GluA3 antibodies in Frontotemporal Dementia: from bench to bedside
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
New interventional approaches on multiple inflammatory pathways involved in regeneration after trauma and aging- associated diseases
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Escaping the ESKAPEs: integrated pipelines for new antibacterial drugs
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
|
|
Ongoing | 2022 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Pharmacological block of the prokineticin system and of microglia activation to treat pain and mood disorders in Fabry-Anderson disease
|
|
Ongoing | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
The impact of early life stress in later life (EarlyCause)
|
|
Ongoing | 2022 |
